Articles

DDT debate continues

None | 02 Nov 2009 | Africa Fighting Malaria

On Thursday October 29th, AFM Director Richard Tren had an article published in South Africa's leading daily newspaper, Business Day, discussing new research from University of Pretoria scientists on DDT and human health.

Dubious studies poison war on malaria

Richard Tren | 29 Oct 2009 | Business Day (South Africa)

For years, fear and uncertainty, fuelled by politically driven and misleading information, undermined the fight against HIV/AIDS in SA. The result was the avoidable deaths of more than 300000 people. Now fear and uncertainty are being peddled again, this time against DDT use in malaria control.

A response to the paper entitled "DDT and urogenital malformations in newborn boys in a malarial area"

None | 26 Oct 2009 | Africa Fighting Malaria

For six decades dichloro-diphenyl-trichloroethane (DDT) has been used successfully in indoor residual spraying programs to control malaria. During the many decades that DDT has been in use, thousands of tonnes of the chemical have been produced and used throughout the world with millions of people coming into direct contact with it in one way or another.

March of Washingtons - Update from Uganda

None | 05 Oct 2009 | Africa Fighting Malaria

In May 2009, the March of Washingtons distributed $30,000 to Soft Power Health for the purchase and distribution of antimalarial drugs in Uganda. Click here to watch a video update from Uganda.

India's Counterfeit Claims on Counterfeit Drugs

Roger Bate | 01 Oct 2009 | American.com

The Indian government is touting a new survey showing a low percentage of drugs within the country are counterfeit. But the reality is that India still has a major problem with poor-quality drugs.

Protectionism Won't Heal Africa's Sick

Roger Bate | 28 Sep 2009 | Wall Street Journal

Donating money to boost African access to essential drugs is a wonderful thing. But unless philanthropists insist on market principles in the continent's drug market, and until they apply necessary due diligence when cutting checks, their aid stands to be hijacked by governmental opportunism, incompetence and corruption.

The push for local production, costs and benefits - A case study of Uganda's Quality Chemicals

None | 02 Sep 2009 | Africa Fighting Malaria

Many Africans lack access to essential medicines. There are myriad reasons for this: poverty, lack of awareness about the need for treatment, confusion over which drugs to take, technical and logistical challenges in procurement and distribution combined with a general lack of local healthcare staff and infrastructure, among other cultural and political factors.

When Local Production Is Not the Answer

Roger Bate | 02 Sep 2009 | American.com

Africa's poor people lack access to essential medicines. Distributional failures, inadequate patient education, and healthcare facilities are key causes, but the relatively high price of drugs also plays its part.

Populations exposed to malaria suffer in silence

Jasson Urbach | 01 Sep 2009 | Health Policy Unit

DDT, one of the most studied insecticides, has again come under attack. In May 2009, Environmental Health Perspectives (EHP) published The Pine River Statement: Human Health Consequences of DDT Use.

Drugs, Importation, and the Internet: A New Study

Roger Bate | 19 Aug 2009 | The New Ledger

The pharmaceutical industry insists importing drugs from overseas will be a danger to American patients. There is certainly evidence to back up their claim with a growing number of deaths directly caused by dangerous drugs coming from overseas, mainly from China.